Sirion Therapeutics

About:

Sirion Therapeutics is a biopharmaceutical company, engaged in developing, and commercializing of products for the protection of eyesight.

Website: https://www.siriontherapeutics.com/

Top Investors: Advent International, Atlas Venture, Aisling Capital, Novaquest Capital Management, Investor Growth Capital Limited

Description:

Sirion Therapeutics is a Tampa, FL-based company dedicated to the development and commercialization of innovative ophthalmic products.

Total Funding Amount:

$45M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Tampa, Florida, United States

Founded Date:

2005-01-01

Founders:

Barry Butler, Philippe Boulangeat

Number of Employees:

101-250

Last Funding Date:

2007-04-10

IPO Status:

Private

Industries:

© 2025 bioDAO.ai